NCT05983874Active, not recruitingPhase 1
IAVI C110 HIV Vaccine Trial
Source: EU CTIS (euclinicaltrials.eu) · Last updated 9 Feb 2024
- Status (registry)
- Active, not recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 6 (estimated)
- First submitted
- 11 Oct 2023
- Start date
- 19 Mar 2024
- Lead sponsor
- International AIDS Vaccine Initiative Inc.
- Diseases
- HIV
- NCT number
- NCT05983874
- EU CT number
- 2023-508157-15-01
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 6
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Amsterdam UMC Coordinator of this site? Confirm its status | Amsterdam | Netherlands | Active, not recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.